即时询价 ×
* 必填项
请填妥以下表格,您将在一分钟内得到邮件机器人给你的报价。
Inquiry Online
×
* Required Fields.
Please complete the form below and we will contact you shortly.
Bulk Inquiry
×
* Required Fields.
Please complete the form below and we will contact you shortly.
CAS号 | 1643913-93-2 | 货号 | BCP10637 |
中文名 | Padnarsertib | ||
英文名 | Padnarsertib | ||
中文别名 | |||
英文别名 | KPT9274;PAK4-IN-1;KPT-9274;KPT 9274; PAK4-IN-1; PAK4-IN 1; PAK4-IN1; | ||
SMILES | C1CN(CCC1(F)F)C(=O)C2=CC=C(C=C2)C3=CC(=C4C(=C3)C=C(O4)CNC(=O)C=CC5=CN=C(C=C5)N)C6=CC=C(C=C6)F | ||
化学名称 | |||
分子式 | C35H29F3N4O3 | 分子量 | 610.63 |
纯度 | 98% | 配送 | 惯例下常温包邮 |
产品描述 | Padnarsertib is a potent, selective and dual PAK4/NAMPT inhibitor. KPT-9274 interferences with PAK4/NAMPT signaling pathways, which results in reduction of G2-M transit as well as induction of apoptosis and decrease in cell invasion and migration in several human RCC cell lines. Mechanistic studies demonstrate that inhibition of the PAK4 pathway by KPT-9274 attenuates nuclear β-catenin as well as the Wnt/β-catenin targets cyclin D1 and c-Myc. KPT-9274 demonstrated the expected on-target effects in this mouse model. KPT-9274 is being evaluated in a phase I human clinical trial in solid tumors and lymphomas, which will allow this data to be rapidly translated into the clinic for the treatment of RCC. |
相关产品推荐
查看更多 >Tags:Padnarsertib 供应商,Padnarsertib 购买,Padnarsertib 生产,Padnarsertib 批量,Padnarsertib 供应,Padnarsertib 订购,Padnarsertib 采购